Is REGENXBIO Inc. overvalued?

REGENXBIO Inc. (RGNX) — key valuation metrics and fundamentals.

No verdict

Price

$7.64

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$505.2M

Dividend yield

0.0%

Return on equity

-204.0%

Sector

Healthcare

Fair value compares RGNX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks